Targeting sphingosine-1-phosphate for cancer therapy
Open Access
- 3 October 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (9), 1131-1135
- https://doi.org/10.1038/sj.bjc.6603400
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during DevelopmentMolecular and Cellular Biology, 2006
- Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse ModelsCancer Research, 2005
- Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomicsProstaglandins & Other Lipid Mediators, 2005
- Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720Published by Elsevier BV ,2004
- Sphingosine-1-phosphate Signaling Promotes Critical Migratory Events in VasculogenesisPublished by Elsevier BV ,2004
- Sphingosine 1‐phosphate transactivates c‐Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cellsFEBS Letters, 2004
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Regulation of limb development by the sphingosine 1-phosphate receptor S1p1/EDG-1 occurs via the hypoxia/VEGF axisDevelopmental Biology, 2004
- Sphingosine-1-phosphate: an enigmatic signalling lipidNature Reviews Molecular Cell Biology, 2003
- Tumors: Wounds That Do Not HealThe New England Journal of Medicine, 1986